亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

肉豆蔻酰三肽-31
 
 
單價(jià) ￥3.00 / mg對(duì)比
銷量 暫無(wú)
發(fā)貨 四川成都市付款后3天內(nèi)
庫(kù)存 1000mg起訂50mg
品牌 成都云希
過(guò)期 長(zhǎng)期有效
更新 2021-07-02 10:05
 

成都云希化工有限公司

企業(yè)會(huì)員第6年
資料未認(rèn)證
保證金未繳納
詳細(xì)說(shuō)明

Myristoyl Tripeptide-31

Characteristics:

Myristoyl Tripeptide-31 is a alternative to retinoic acid to help reverse appearance of wrinkles, mottled hyper-pigmentation and can be a powerful substitute for retinoids without any side effects.

Cosmetic Functions:

Anti-wrinkle for face and body

Increase of collagen synthesis

Providing exceptional anti-aging benefits

Whitening effect

Skin pore contraction

Myristoyl Tripeptide-31 肉豆蔻酰三肽-31

舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
云希專注勝肽乙酰基六肽-49/DELISENS 乙酰基六肽-1 乙酰基四肽-2 三肽-10瓜氨酸/核心蛋白聚糖肽 Polypeptide-23 乙酰基六肽-7抗衰多肽 Sh-Decapeptide-7 Oligopeptide-21/寡肽21
網(wǎng)站首頁(yè)  |  VIP介紹  |  VIP區(qū)別  |  VIP優(yōu)勢(shì)  |  成功案例  |  聯(lián)系方式  |  韓國(guó)REACH(K-REACH)注冊(cè)  |  化工網(wǎng)會(huì)員活動(dòng)  |  ERP管理系統(tǒng)  |  化學(xué)網(wǎng)站建設(shè)  |  關(guān)于Chem234  |  網(wǎng)站地圖  |  排名推廣  |  廣告服務(wù)  |  積分換禮  |  RSS訂閱  |  違規(guī)舉報(bào)  |  魯ICP備14010393號(hào)-3
 
主站蜘蛛池模板： | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |